- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01536912
Medical Marijuana Use in HIV+ Patients: Probability Survey (MMS)
Behavioral Economic Analysis of Medical Marijuana Use in HIV+ Patients: Probability Survey
More scientific information is needed about medical marijuana use among HIV positive patients. There is conflicting information about the use of marijuana, use of medical marijuana, and the associations between them and health status/health risk behaviors/health care utilization. In addition, it is not clear whether patients who participate in prospective clinical studies differ from participants who do not participate; if there are differences between those two groups, then this would limit generalizability of knowledge about these issues.
The goal of this project is to describe the use of marijuana among HIV positive patients and its association with health status/health risk behaviors/health care utilization.
Study Overview
Status
Conditions
Detailed Description
Participants will answer questions about marijuana, medical marijuana, and other drug use. We will also ask about health and steps participants take to keep healthy. The study will take up to one hour to complete.
Participants will also be asked to sign a release of information form. This form would allow us to look at medical records at the HIV clinic.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Michigan
-
Detroit, Michigan, United States, 48201
- Wayne State University (HIV clinic, Tolan Park Medical Building)
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients in the HIV clinic
- HIV positive
Exclusion Criteria:
- Lack of english
Study Plan
How is the study designed?
Design Details
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Mental Disorders
- Substance-Related Disorders
- RNA Virus Infections
- Virus Diseases
- Infections
- Blood-Borne Infections
- Communicable Diseases
- Sexually Transmitted Diseases, Viral
- Sexually Transmitted Diseases
- Lentivirus Infections
- Retroviridae Infections
- Immunologic Deficiency Syndromes
- Immune System Diseases
- HIV Infections
- HIV Seropositivity
- Marijuana Use
Other Study ID Numbers
- MMS-1
- R01DA032678 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV Positive
-
University of California, San DiegoUniversity of California, Los Angeles; University of Southern California; California... and other collaboratorsCompleted
-
Gérond'ifRecruiting
-
University of California, San DiegoNational Center for Complementary and Integrative Health (NCCIH)CompletedHIV PositiveUnited States
-
HIV Prevention Trials NetworkNational Institute on Drug Abuse (NIDA); National Institute of Allergy and...CompletedHIV PositiveIndonesia, Ukraine, Vietnam
-
Therapeutic ConceptsJanssen Scientific Affairs, LLCUnknown
-
University of WashingtonSeattle Children's Hospital; University of NairobiCompleted
-
Universidad Autónoma del Estado de HidalgoNational Council of Science and Technology, MexicoCompleted
-
Bayside HealthMerck Sharp & Dohme LLCUnknown
-
Holdsworth House Medical PracticeCompleted
-
Absolute Return for KidsUnited States Agency for International Development (USAID); Department for... and other collaboratorsCompleted